by Brenda Watson | Mar 21, 2012 | General
In February of this year the FDA issued advice on the risks of taking statin drugs. They warn that people being treated with statins may be at increased risk for developing type 2 diabetes, and that cognitive impairment, such as memory loss, forgetfulness, and...
by Brenda Watson | Aug 24, 2011 | General
It is reported that the pharmaceutical company Pfizer, which manufactures the cholesterol-lowering drug atorvastatin (Lipitor), will attempt to gain FDA approval to sell the drug over the counter. The patent on Lipitor expires in November, which means that generic...
by Brenda Watson | Feb 3, 2011 | General
February 1st marked the start of American Heart Month, an annual awareness effort from the American Heart Association to bring attention to cardiovascular disease being our nation’s No. 1 killer. And while it’s important to bring this issue to light, I...
